000			01926 a2200565 4500
005			20250517043411.0
264		0	_c20151116
008			201511s 0 0 eng d
022			_a1879-3169
024	7		_a10.1016/j.toxlet.2015.07.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aEmerce, Esra
245	0	0	_aDetermination of the impurities in drug products containing montelukast and in silico/in vitro genotoxicological assessments of sulfoxide impurity. _h[electronic resource]
260			_bToxicology letters _cOct 2015
300			_a90-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetates _xanalysis
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aAnti-Asthmatic Agents _xanalysis
650	0	4	_aCells, Cultured
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aChromatography, High Pressure Liquid
650	0	4	_aChromatography, Reverse-Phase
650	0	4	_aChromosome Aberrations _xchemically induced
650	0	4	_aComputer Simulation
650	0	4	_aCyclopropanes
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Contamination
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Bacterial _xdrug effects
650	0	4	_aHumans
650	0	4	_aLeukotriene Antagonists _xanalysis
650	0	4	_aLymphocytes _xdrug effects
650	0	4	_aMale
650	0	4	_aMitosis _xdrug effects
650	0	4	_aMitotic Index
650	0	4	_aMutagenicity Tests
650	0	4	_aMutation
650	0	4	_aQuinolines _xanalysis
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aRisk Assessment
650	0	4	_aSulfides
650	0	4	_aSulfoxides _xanalysis
650	0	4	_aTurkey
700	1		_aCok, Ismet
700	1		_aDegim, I Tuncer
773	0		_tToxicology letters _gvol. 238 _gno. 2 _gp. 90-9
856	4	0	_uhttps://doi.org/10.1016/j.toxlet.2015.07.003 _zAvailable from publisher's website
999			_c25103866 _d25103866